| Literature DB >> 27590338 |
Nguyen-Hung Le1, Virginie Molle2, Nathalie Eynard1, Mathieu Miras1, Alexandre Stella1, Fabienne Bardou1, Ségolène Galandrin1, Valérie Guillet1, Gwenaëlle André-Leroux3, Marco Bellinzoni3, Pedro Alzari3, Lionel Mourey1, Odile Burlet-Schiltz1, Mamadou Daffé4, Hedia Marrakchi5.
Abstract
Mycolic acids are essential components of the mycobacterial cell envelope, and their biosynthetic pathway is a well known source of antituberculous drug targets. Among the promising new targets in the pathway, FadD32 is an essential enzyme required for the activation of the long meromycolic chain of mycolic acids and is essential for mycobacterial growth. Following the in-depth biochemical, biophysical, and structural characterization of FadD32, we investigated its putative regulation via post-translational modifications. Comparison of the fatty acyl-AMP ligase activity between phosphorylated and dephosphorylated FadD32 isoforms showed that the native protein is phosphorylated by serine/threonine protein kinases and that this phosphorylation induced a significant loss of activity. Mass spectrometry analysis of the native protein confirmed the post-translational modifications and identified Thr-552 as the phosphosite. Phosphoablative and phosphomimetic FadD32 mutant proteins confirmed both the position and the importance of the modification and its correlation with the negative regulation of FadD32 activity. Investigation of the mycolic acid condensation reaction catalyzed by Pks13, involving FadD32 as a partner, showed that FadD32 phosphorylation also impacts the condensation activity. Altogether, our results bring to light FadD32 phosphorylation by serine/threonine protein kinases and its correlation with the enzyme-negative regulation, thus shedding a new horizon on the mycolic acid biosynthesis modulation and possible inhibition strategies for this promising drug target.Entities:
Keywords: cell wall; lipid metabolism; mycobacteria; post-translational modification (PTM); protein phosphorylation
Mesh:
Substances:
Year: 2016 PMID: 27590338 PMCID: PMC5077212 DOI: 10.1074/jbc.M116.748053
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157